The Senescence Problem
Cellular senescence is a state where damaged cells stop dividing but refuse to die. These "zombie cells" accumulate with age, secreting a toxic cocktail of inflammatory cytokines called the SASP (Senescence-Associated Secretory Phenotype). SASP drives chronic systemic inflammation, tissue dysfunction, and accelerated aging.
Senolytics are compounds that selectively induce apoptosis (programmed cell death) in these senescent cells while leaving healthy cells intact.
FOXO4-DRI Mechanism
In senescent cells, the FOXO4 protein physically binds and sequesters p53—the tumor suppressor that would normally trigger apoptosis. This FOXO4-p53 interaction is what keeps zombie cells alive.
FOXO4-DRI is a D-retro-inverso peptide (mirror-image, protease-resistant) that competitively disrupts this FOXO4-p53 interaction. When FOXO4-DRI displaces FOXO4, p53 is released to the mitochondria, where it activates the BAX/BAK apoptotic cascade. The senescent cell dies.
Research Status
FOXO4-DRI showed remarkable results in aged mice: restoration of fitness, fur density, and renal function. However, it remains strictly a research peptide with no human clinical trials completed. Dosing protocols are extrapolated from murine data and highly experimental.
